2,7-Dibromo-9H-fluorene

IUPAC Name: 2,7-dibromo-9H-fluorene

Synonyms: 2,7-Dibromofluorene, 9H-Fluorene, 2,7-dibromo-, Fluorene, 2,7-dibromo-, Dibromofluorene

Catalog NO.:
CAS NO.: 16433-88-8
Brand: Daisa Biopharma
Category: Intermediate
Tag: 4-1-Bromo-8-chloronaphthalene, Adgrasib intermediate

Molecular Formula: C13H8Br2

Molecular Weight: 324.01
Pack Size Available: 5 g, 100 g, 1.0 kg
Place of Origin: India

0 People watching this product now!

cGMP Capacity

kg to MT scale
GMP batches production
Over 20 years of experience

HPAPI production with OEL < 1 μg/m³
Cleanroom Class 100 to Class 100,000
Special type of reactions in cGMP workshop

Cleaning level: Class A B C
cGMP synthesis workshop

Product Description

  • Acts as a monomer for the synthesis of highly efficient and stable conjugated polymers and oligomers, crucial for OLED displays and lighting applications.
  • Used in the preparation of donor monomers for semiconducting polymers in organic electronics.
  • Serves as a precursor for specialized polyelectrolytes (e.g., PFN) employed in organic electronic devices.

Appearance: White solids

Melting Points: 166 oC

HPLC purity: ≥98% a/a

NMR: Confirm the structure

Physical Form: Solid

Shipping Temperature: Keep the container tightly closed in a dry, well-ventilated area. Containers that are opened must be carefully resealed and kept upright to prevent leakage. Inert atmosphere, Room Temperature

Storage Temperature: Keep container tightly closed in a dry and well-ventilated area. Containers that are opened must be carefully resealed and kept upright to prevent leakage. Inert atmosphere, Room Temperature

Inchi Code:1S/C13H8Br2/c14-10-1-3-12-8(6-10)5-9-7-11(15)2-4-13(9)12/h1-4,6-7H,5H2

SMILES: C1C2=C(C=CC(=C2)Br)C3=C1C=C(C=C3)Br

140073

About Us

We are a multidisciplinary research organization specializing in Medicinal Chemistry, Process Chemistry, and Biocatalysis—delivering scalable, efficient, and sustainable solutions for complex scientific challenges.

Our medicinal chemistry division drives early-stage drug discovery through the design and synthesis of novel chemical entities, SAR exploration, and creation of natural-product-inspired molecular libraries.

We develop safe, robust, and scalable synthetic routes for APIs and intermediates. Our expertise covers QbD-driven development, impurity profiling, polymorph optimization, and complete CMC/DMF support.

Our biocatalysis services include enzyme screening, whole-cell bioconversion, and industrial bioprocess scale-up—enabling greener, more cost-effective, and sustainable alternatives to traditional chemical transformations.

Our Clients